Celldex Therapeutics | CLDX - SCHULD





SCHULD Veränderung Datum
AbbVie USD 72.86B 5.36B 2026-03
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 57.32B 2.72B 2026-03
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Celldex Therapeutics USD 1.91M 428K 2026-03
Glaxosmithkline GBP 19.06B 1.31B 2026-03
Nektar Therapeutics USD 0 0 2022-06
Northwest Biotherapeutics USD 32.94M 6.93M 2023-09
Pfizer USD 63.19B 536M 2026-06
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06